CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma
2022 · Molecular Therapy · 181 citations
https://doi.org/10.1016/j.ymthe.2022.08.021
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
273
Citations
3
h-index
3
i10-index
Boyang Yuan is an academic researcher from Sichuan University. The author has contributed to research in topics: CAR-T cell therapy research & Immunotherapy and Immune Responses & Glioma Diagnosis and Treatment. The author has an h-index of 3, co-authored 5 publications.
https://doi.org/10.1016/j.ymthe.2022.08.021
https://doi.org/10.1155/2022/8426384
Click to start Chat